Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$15.18
$15.96
0.785.14%
After Hours: Jan 16, 4:00 PM EST
Comments
Loading...
Seres Therapeutics (MCRB) Stock Price, Quote, News & History
MCRBNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Seres Therapeutics (MCRB) stock?
You can purchase shares of Seres Therapeutics (NASDAQ:MCRB) through any online brokerage.
Who are Seres Therapeutics (MCRB) competitors?
Other companies in Seres Therapeutics’s space includes: Molecular Partners AG (NASDAQ:MOLN), Connect Biopharma Holdings Ltd (NASDAQ:CNTB), Elicio Therapeutics Inc (NASDAQ:ELTX), Fate Therapeutics Inc (NASDAQ:FATE) and Whitehawk Therapeutics Inc (NASDAQ:WHWK).
What is the forecast, or price target, for Seres Therapeutics (MCRB) stock?
Seres Therapeutics has a consensus price target of $13.15.
What is the current price for Seres Therapeutics (MCRB)?
The stock price for Seres Therapeutics (NASDAQ: MCRB) is $15.96 last updated January 16, 2026 at 4:00 PM EST.
Does Seres Therapeutics (MCRB) pay a dividend?
There are no upcoming dividends for Seres Therapeutics.
When is Seres Therapeutics (NASDAQ:MCRB) reporting earnings?
Seres Therapeutics does not have any upcoming earnings scheduled.
Is Seres Therapeutics (MCRB) going to split?
There is no upcoming split for Seres Therapeutics.
What sector and industry does Seres Therapeutics (MCRB) operate in?
Seres Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
